Education
About Us
Working with TipRanks
Follow Us
Sensus Healthcare (SRTS)
NASDAQ:SRTS
SRTS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.53 - $9.33
Previous CloseN/A
Volume208.66K
Average Volume (3M)106.27K
Market Cap
$71.43M
Enterprise Value$92.32M
Total Cash (Recent Filing)$22.06M
Total Debt (Recent Filing)$602.00K
Price to Earnings (P/E)10.6
Beta1.37
Next Earnings
Jul 31, 2025EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.41
Shares Outstanding16,495,396
10 Day Avg. Volume81,875
30 Day Avg. Volume106,273
Financial Highlights & Ratios
PEG Ratio0.00834
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.78
Enterprise Value/Ebitda11.07
Forecast
1Y Price Target
$12.25Price Target Upside182.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Sensus Healthcare News
PremiumCompany Announcements
Sensus Healthcare Earnings Call Highlights Robust Growth---
Bulls Say, Bears Say
Bulls Say
Growth ProspectsSensus signed additional Fair Deal Agreement revenue-sharing programs and has multiple new agreements in the pipeline, indicating future growth prospects.
Market DemandThe company shipped a record number of SRT systems in FY2024, exceeding expectations and showing strong market demand.
Revenue GrowthSensus Healthcare reported a 71% year-over-year revenue growth for FY2024, beating projections and supporting a Buy rating.
Bears Say
Customer RelationshipThe most common investor concern we have encountered recently is Sensus’ relationship with their largest customer, SkinCure Oncology.
Investment RisksInvestment risks include potential failure of SRT or TransDermal Infusion systems to achieve commercial success due to reimbursement, penetration rate, and competition.
Revenue Projections2025 revenue projections adjusted lower; growth over 2024 still expected.
---
Ownership Overview
11.45% Insiders
8.10% Mutual Funds
3.51% Other Institutional Investors
70.90% Public Companies and
Individual Investors
SRTS FAQ
What was Sensus Healthcare’s price range in the past 12 months?
Sensus Healthcare lowest stock price was $3.53 and its highest was $9.33 in the past 12 months.
What is Sensus Healthcare’s market cap?
Sensus Healthcare’s market cap is $71.43M.
When is Sensus Healthcare’s upcoming earnings report date?
Sensus Healthcare’s upcoming earnings report date is Jul 31, 2025 which is in 89 days.
How were Sensus Healthcare’s earnings last quarter?
Currently, no data Available
Is Sensus Healthcare overvalued?
According to Wall Street analysts Sensus Healthcare’s price is currently Undervalued.
Does Sensus Healthcare pay dividends?
Sensus Healthcare does not currently pay dividends.
What is Sensus Healthcare’s EPS estimate?
Sensus Healthcare’s EPS estimate is 0.03.
How many shares outstanding does Sensus Healthcare have?
Sensus Healthcare has 16,495,396 shares outstanding.
What happened to Sensus Healthcare’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sensus Healthcare?
Among the largest hedge funds holding Sensus Healthcare’s share is Sheaff Brock Investment Advisors LLC. It holds Sensus Healthcare’s shares valued at 0.
---
Sensus Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.25 (182.91% Upside)
$12.25 (182.91% Upside)
Blogger Sentiment
Bullish
SRTS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 40.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $8.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.94%
12-Months-Change
Fundamentals
Return on Equity
12.70%
Trailing 12-Months
Asset Growth
15.74%
Trailing 12-Months
Company Description
Sensus Healthcare
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
---
SRTS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive outlook for Sensus Healthcare, highlighted by strong revenue growth and profitability, successful product sales, and strategic initiatives like the Fair Deal Agreement program. However, challenges such as decreased gross profit margins and increased operating expenses were noted. The company's expansion into international markets and new sectors like veterinary medicine are promising, although seasonality may impact near-term sales.Read More>---
SRTS Stock 12 Month Forecast
Average Price Target
$12.25
▲(182.91% Upside)
Technical Analysis
---